Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.31 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19402606 | 0.76 | TSHR (0.36) | TSHRKDM4EMAPTGSK3BADORA3 | |
| SCHEMBL19402609 | 0.76 | TSHR (0.36) | TSHRKDM4EMAPTGSK3BADORA3 | |
| SCHEMBL8807973 | 0.69 | KDM4E (0.48) | TSHRKDM4EMAPTGSK3BADORA3 | |
| SCHEMBL31546962 | 0.68 | TSHR (0.43) | TSHRKDM4EMAPTGSK3B | |
| SCHEMBL12461900 | 0.67 | TAAR1 (0.35) | — | |
| SCHEMBL19402604 | 0.65 | TSHR (0.41) | TSHRKDM4EMAPTGSK3BADORA3 | |
| SCHEMBL13833511 | 0.64 | TSHR (0.59) | TSHRKDM4EMAPTGSK3BADORA3 | |
| SCHEMBL4105591 | 0.61 | MGAM (0.46) | KDM4EMAPT | |
| SCHEMBL6756153 | 0.61 | KDM4E (0.44) | TSHRKDM4EMAPTGSK3BADORA3 | |
| SCHEMBL4053441 | 0.60 | ADORA3 (0.40) | TSHRKDM4EMAPTGSK3BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2274300-A2 | NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF | Novartis AG (CH) | 2011-01-19 | — | — | EP | disclosed |
| WO-2009115572-A2 | NOVEL HETEROCYCLIC COMPOUNDS AND USES THEROF | NOVARTIS AG (CH) | 2009-09-24 | — | — | WO | disclosed |